Alphatec Holdings Inc. (ATEC) Options Positioning, Max Pain & Unusual Sweeps

$7.04 -38.08% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.54

Alphatec Holdings Inc. (ATEC) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D β€’ SELL / AVOID Cap $1.76B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ATEC Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is ATEC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Alphatec Holdings Inc. (NASDAQ: ATEC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $7.04 (-38.08% 1D, market cap $1.76B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ATEC ranks #372 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does ATEC compare to KMTS and XRAY in the Health Care sector?
β–Ό

Within the Health Care sector (Medical/Dental Instruments), ATEC carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 69.6%, and ROIC of -18.4%. By comparison, KMTS (Kestra Medical Technologies Ltd.) holds a D grade (50/100 RQD, P/E N/A, ROIC -35.0%, cap $1.82B) and XRAY (DENTSPLY SIRONA Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, LMAT leads on earnings multiple (33.8x) while LMAT leads on capital efficiency (14.7% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ATEC?
β–Ό

Per ATEC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001350653), Alphatec Holdings Inc. generated $764.2M in revenue (+25.0% YoY), -$143.4M in net income, and $2.8M in free cash flow against $791.2M in total assets and $501.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $6.54 (-7.04%)🧬 Dilution Drag (+1.92% YoY Shares)βš™οΈ Cash Engine: 12/20 (C-) β€’ 0.4% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (46/100 Β· D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D
025507510046
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D Β· Rk D-
Cash (12)Whales (13)SEC (9)Macro (7)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-5.4% Base Target
$24 Bull$7 Base$5 Bear
πŸ“¬ FREE ATEC RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for ATEC)Realized 20D OHLCV Swing Band: Β±11.4%
Deterministic 5-Pillar Attribution (46/100 Composite)
πŸ” WHY ATEC SCORES 46/100 (D) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Whale & Options Positioning+13/20 pts (28% of score)

20D Institutional Volume Accumulation (Β±11.4% realized swing band)

β–² #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 0.4% FCF Margin ($2.8M FCF) & 69.6% Gross Margin

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
54
Grade C-$11.25-7.5% Next Q
Q2 (-2Q)
51
Grade C-$10.41+4.7% Next Q
Q3 (-1Q)
49
Grade D$10.90-35.4% Next Q
Current
46
Grade D$7.04-6.1% Hist 90D Ξ±
Trajectory: C- (54) β†’ D (46)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a ATEC Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While ATEC currently carries a cautious 46/100 (D) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.18) and Max Pain ($7.39) forces dealer call-delta covering toward $24.45.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ATECβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œATEC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
CALL VS. PUT WHALE SHARE
β€” (No Active Options Snapshot)
Put/Call Ratio: β€” (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
β€” (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
Β±11.4%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (ATEC)

β€” (No Active Options Snapshot) β€” No unusual CBOE strike concentration anomalies recorded in the current database snapshot for ATEC.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

πŸ† Enter Free $100K Paper Arena β†’
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ATEC)

  • βœ“Walkthrough of ATEC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ATEC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -31.85%β–Ό SUPPORT BREAKDOWN
2026-11-02O $11.45H $11.45L $7.04C $7.04VOL 7.22M
RES: $12.26SUP: $9.22SMA50: $10.18SMA200: $10.53
$15.99$13.50$11.01$8.53$6.04RES $12.26SUP $9.22$7.042026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ATEC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ATEC today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for ATEC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ATEC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ATEC)

1. Head-to-Head Health Care Peer Comparison (ATEC vs. KMTS, XRAY, LMAT, NVCR)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Alphatec Holdings Inc. (ATEC) ranks #372 by composite RQD confidence (46/100, grade D) and #280 by equity capitalization ($1.76B). Within this direct 5-issuer industry benchmark cohort, LMAT leads on earnings valuation at 33.8x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. LMAT currently holds the highest overall quantitative score in the immediate peer group at 69/100 (C+) compared with ATEC at 46/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ATEC ACTIVE
Alphatec Holdings Inc.
D 46/100 β€” 69.6% -18.4% -38.08% $1.76B Benchmark Subject
KMTS
Kestra Medical Technologies Ltd.
D 50/100 β€” 51.4% -35.0% -3.01% $1.82B /kmts-vs-atec β†’
XRAY
DENTSPLY SIRONA Inc.
E 32/100 β€” 50.0% -11.0% -0.83% $1.92B /xray-vs-atec β†’
LMAT
LeMaitre Vascular Inc.
C+ 69/100 33.8x 71.5% 14.7% -5.08% $1.95B /lmat-vs-atec β†’
NVCR
NovoCure Limited
E 21/100 β€” 74.5% -27.5% +0.31% $1.53B /nvcr-vs-atec β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001350653

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alphatec Holdings Inc. (ATEC) reported GAAP revenue of $764.2M (+25.0% vs. FY2024 revenue of $611.6M ) , GAAP net income of -$143.4M, operating cash flow of $45.2M, and free cash flow of $2.8M (+102.2% YoY). On the balance sheet, ATEC closed FY2025 with $791.2M in total assets against $501.4M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $764.2M -$143.4M $45.2M $2.8M $791.2M $501.4M
FY2024 (FY) 2024-12-31 $611.6M -$162.1M -$44.7M -$127.9M $775.7M $574.5M
FY2023 (FY) 2023-12-31 $0 -$186.6M -$78.5M -$78.5M β€” β€”

3. ATEC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ATEC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Alphatec Holdings Inc. (NASDAQ: ATEC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $7.04 (-38.08% 1D, market cap $1.76B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ATEC ranks #372 in composite RQD confidence.

How does ATEC compare to KMTS and XRAY in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), ATEC carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 69.6%, and ROIC of -18.4%. By comparison, KMTS (Kestra Medical Technologies Ltd.) holds a D grade (50/100 RQD, P/E N/A, ROIC -35.0%, cap $1.82B) and XRAY (DENTSPLY SIRONA Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, LMAT leads on earnings multiple (33.8x) while LMAT leads on capital efficiency (14.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ATEC?

Per ATEC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001350653), Alphatec Holdings Inc. generated $764.2M in revenue (+25.0% YoY), -$143.4M in net income, and $2.8M in free cash flow against $791.2M in total assets and $501.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ATEC trading relative to its 50-day, 200-day, and 52-week technical levels?

ATEC last traded at $7.04 (-38.08% on volume of 27,299,430 shares), positioning the stock -30.84% below its 50-day simple moving average ($10.18) and -33.14% below its 200-day simple moving average ($10.53). Across its 52-week range of $6.81 to $23.29, ATEC sits at the 1.4% percentile with a 14-day RSI of 54.1 (NEUTRAL RANGE) and an implied next-earnings move of Β±11.4% ($6.24 to $7.84).

ATEC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

What is ATEC's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for ATEC.

ROARABLE RATING BRIEF β€’ RQD 46/100 (D) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

ATEC β€” Alphatec Holdings Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:27:53Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD rating is 46 out of 100, a letter grade of D, with the verdict "Roarable Sell β€” Underperform / Distribution Warning" (per the Roarable RQD rating). The five pillars score as follows:

  • Fundamental Cash Engine: 12 / 20. The rating cites ROIC of -18.4% and an FCF yield of 0.16%. For a prospective investor, this indicates the business is not currently generating meaningful returns on invested capital, and the cash yield offers little valuation support at the current price.
  • Whale 13F Flow: 13 / 20. The rating describes institutional accumulation and options positioning. This is the strongest pillar, suggesting some institutional interest, though the source data does not itemize the holdings (see Analyst View section).
  • Insider Conviction: 5 / 20. The rating references SEC Form 4 and Congressional PTR cluster flow, scored low. This is the weakest pillar, indicating limited insider signal of confidence.
  • Macro Regime Fit: 7 / 20. The rating lists a beta of 1.0 and sector sensitivity as the basis. For an investor, this means the stock is expected to move in line with the broad market while carrying sector-specific exposure, without a clear macro tailwind identified in the source data.
  • Forensic Balance Sheet: 9 / 20. The rating cites an Altman Z-Score of 2.5, a Piotroski F-Score of 6/9, and Debt/Equity of 8.5. These point to a leveraged balance sheet with moderate financial-health signals, which constrains downside tolerance.

Taken together, the rating frames ATEC as a stock where operating losses, thin free cash flow, and leverage outweigh the institutional-flow signal. Upside drivers would need to come from margin recovery and improved cash conversion, which the current data does not show. The 52-week range of $6.81 - $23.29 against a price of 11.37 illustrates how wide the trading band has been, which increases volatility risk for a prospective investor. This is an educational summary of the rating's components, not personalized financial advice.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$764.2M$-82.1M$-143.4MN/A$2.8M$160.8M$501.4M
FY 2024$611.6M$-136.2M$-162.1MN/A$-127.9M$138.8M$574.5M
FY 2023$0.0M$-173.4M$-186.6MN/A$-78.5MN/AN/A

Per the SEC financials, the company reported operating losses in all three periods, narrowing from $-173.4M (FY 2023) to $-82.1M (FY 2025) while revenue grew from $611.6M (FY 2024) to $764.2M (FY 2025). Per the market data, gross margin is 69.6%, operating margin -10.7%, and net margin -18.8%. ROIC is -18.4%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 6/9, with Debt/Equity of 8.5. Debt declined from $574.5M to $501.4M across FY 2024 to FY 2025 while cash rose to $160.8M.

Recent Catalysts & News Wire Analysis

  • Yahoo! Finance Canada (1h ago), MARKET WIRE: General market-action coverage with no specific event described.
  • TradingView (3h ago), MARKET WIRE: Titled as an estimates report; the summary contains no estimate figures.
  • Yahoo Finance (6h ago), MARKET WIRE: Headline references a potential undervaluation tied to cash flow recovery. This is a headline claim, not a verified fact in the data.
  • Moomoo (9h ago), MARKET WIRE: Options chain and quotes page.
  • Yahoo Finance (12h ago), CATALYST, GREEN: Headline references a Madison Small Cap Fund commentary on market share gains and margin expansion potential. This is the only item tagged as a catalyst and the only GREEN item.
  • Yahoo Finance (15h ago), MARKET WIRE: Headline reports Q3 earnings and revenues lagging estimates.

Risk watch: the Q3 earnings miss headline is the most material negative item in the feed. Positive framing rests on the fund commentary and the cash-flow recovery headline, neither of which is quantified in the source data. The Butterfly Supply-Chain Graph reports no supply-chain links and no proprietary signals.

Open Questions

  • What are the company's products, customers, and principal revenue sources?
  • What are the trailing and forward earnings per share and valuation multiples, given P/E, EPS, and EV/EBITDA are absent?
  • What is the composition of the debt load and its maturity profile, given debt is reported without terms?
  • What drove the FY 2024 to FY 2025 revenue increase, and is operating-loss narrowing sustainable?
  • Which institutions hold the stock, and what are the specific insider and 13F transactions behind the rating's flow pillars?

ATEC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Alphatec Holdings Inc. (ATEC) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to ATEC Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ATEC Bull vs. Bear Conversation Board β€” What's Your Call at $7.04?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ATEC 🐻 50% BEARISH CONVICTION
1. Pick Your Side on ATEC:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $12.28 (+8.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is ATEC (D β€’ RQD 46/100) a Buy at $11.37?

Welcome to the ATEC (Alphatec Holdings Inc.) Roar Pit. Current RQD Composite is 46/100 (Roarable Sell β€” Underperform / Distribution Warning) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $8.75 (-23.0%)
Spot @ $11.37

Pump the brakes on ATEC β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ATEC, but look at what you are paying: current EV/EBITDA multiples with 69.6% gross margins. Unless Alphatec Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $14.33 (+26.0%)
Spot @ $11.37

ATEC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ATEC, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $11.37 (52-wk range $6.81 - $23.29), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%